MedTrace Logo

Optimal Placement Duration of Pancreatic Duct Stent

NCT04691674 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 122

Last updated 2024-12-09

No results posted yet for this study

Summary

A randomized controlled trial to determine the optimal placement duration of pancreatic duct stents (PDS) inserted during ERCP: 2 vs 4 weeks

Conditions

  • Cholangitis
  • Post-ERCP Acute Pancreatitis
  • Stent Dislodgement

Interventions

PROCEDURE

Endoscopy

Endoscopic removal of the pancreatic stent

Sponsors & Collaborators

  • Seoul National University Hospital

    collaborator OTHER

  • Gachon University Gil Medical Center

    collaborator OTHER

  • Gyeongsang National University Hospital

    collaborator OTHER

  • Kyungpook National University Hospital

    collaborator OTHER

  • Severance Hospital

    collaborator OTHER

  • The Catholic University of Korea

    collaborator OTHER

  • Korea University Ansan Hospital

    collaborator OTHER

  • Pusan National University Hospital

    collaborator OTHER

  • DongGuk University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-01
Primary Completion
2024-07-31
Completion
2024-08-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04691674 on ClinicalTrials.gov